CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
for infectious pneumonia acquired in the community (CAP), including COVID-19.Secondary objectives:- To determine the effect of repa...
Phase 3
Denver, Colorado, United States of America and 106 other locations
Evaluation of the agreement between fingerstick samples, venous blood, serum and plasma samples when using the LumiraDx SARS-CoV-2 Ab Test against th...
Northglenn, Colorado, United States and 3 other locations
The purpose of this study is to evaluate the safety, reactogenicity, and relative vaccine efficacy (rVE) of the mRNA-1283.222 vaccine as well as its...
Phase 3
Aurora, Colorado, United States and 217 other locations
known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19.The aim of the Phase I/III study (Parent Study) will -...
Phase 2, Phase 3
Aurora, Colorado, United States and 214 other locations
seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...
Phase 3
Aurora, Colorado, United States and 59 other locations
The purpose of this Phase III study is to assess the efficacy, safety, and immunogenicity of two CoV2 preS dTM-AS03 vaccines (monovalent and bivalent...
Phase 3
Centennial, Colorado, United States and 93 other locations
studies or substudies based on age group and prior history of COVID-19 vaccinations. All participants in each of the 5 sub-studies ...
Phase 2, Phase 3
Highlands Ranch, Colorado, United States and 114 other locations
the study vaccine (called COMIRNATY) for the potential prevention of COVID-19. This study is seeking participants who:1. Are age \<...
Phase 4
Aurora, Colorado, United States and 39 other locations
improve lung function in patients that were hospitalized for severe COVID-19-related illness and continue to experience post-acute ...
Phase 2
Aurora, Colorado, United States and 3 other locations
This study will evaluate the safety and immunogenicity of the mRNA-1273.214 vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)...
Phase 3
Aurora, Colorado, United States and 60 other locations
Clinical trials
Research sites
Resources
Legal